Masaaki Ichinoe

Sagamihara, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Association Between Kita-Kyushu Lung Cancer Antigen-1 Positivity and Pathological High-grade Lung Adenocarcinoma.

Association Between Kita-Kyushu Lung Cancer Antigen-1 Positivity and Pathological High-grade Lung Adenocarcinoma.

Journal: Anticancer research

Published: May 29, 2026

CD109 Expression in Tumor and Stromal Cells Serves as a Prognostic Biomarker for Tumor Progression and Outcome in Gallbladder Adenocarcinoma.

CD109 Expression in Tumor and Stromal Cells Serves as a Prognostic Biomarker for Tumor Progression and Outcome in Gallbladder Adenocarcinoma.

Journal: Pathology international

Published: October 25, 2025

Clinical Significance and Preoperative Prediction of High-Grade Subtypes in Early-Stage Lung Adenocarcinoma Eligible for Sublobar Resection.

Clinical Significance and Preoperative Prediction of High-Grade Subtypes in Early-Stage Lung Adenocarcinoma Eligible for Sublobar Resection.

Journal: Journal of surgical oncology

Published: July 02, 2025

REV7 Expression Is Associated with Tumor Cell Growth and Cisplatin Resistance in Gallbladder Adenocarcinoma.

REV7 Expression Is Associated with Tumor Cell Growth and Cisplatin Resistance in Gallbladder Adenocarcinoma.

Journal: Pathobiology : journal of immunopathology, molecular and cellular biology

Published: June 22, 2025

Insight Into the Significance of CD8+ Tumor-Infiltrating Lymphocytes in Lung Adenocarcinoma.

Insight Into the Significance of CD8+ Tumor-Infiltrating Lymphocytes in Lung Adenocarcinoma.

Journal: Thoracic cancer

Published: April 16, 2025

REV7 subunit of mutagenic DNA polymerase ζ as a predictive biomarker for the efficacy of immune checkpoint inhibitor therapy in melanoma.

REV7 subunit of mutagenic DNA polymerase ζ as a predictive biomarker for the efficacy of immune checkpoint inhibitor therapy in melanoma.

Journal: Journal of clinical pathology

Published: April 10, 2025

Elevated expression of REV7 correlates with poor prognosis in lung adenocarcinoma and its inactivation in carcinoma cells enhances chemosensitivity.

Elevated expression of REV7 correlates with poor prognosis in lung adenocarcinoma and its inactivation in carcinoma cells enhances chemosensitivity.

Journal: Pathology, research and practice

Published: October 25, 2024

High levels of REV7 expression are associated with poor prognosis and chemoresistance in gastric adenocarcinoma.

High levels of REV7 expression are associated with poor prognosis and chemoresistance in gastric adenocarcinoma.

Journal: Pathology international

Published: September 07, 2024

Radiologic Parameters Predicting the Histologic Invasiveness of Pure Ground-Glass Nodules.

Radiologic Parameters Predicting the Histologic Invasiveness of Pure Ground-Glass Nodules.

Journal: Annals of thoracic surgery short reports

Published: February 26, 2024

Tumor thickness as a novel risk factor for lymph node metastasis by superficial squamous cell carcinoma of head and neck.

Tumor thickness as a novel risk factor for lymph node metastasis by superficial squamous cell carcinoma of head and neck.

Journal: Cancer science

Published: December 01, 2023

Insight into the significance of Foxp3 + tumor-infiltrating lymphocytes in squamous cell lung cancer.

Insight into the significance of Foxp3 + tumor-infiltrating lymphocytes in squamous cell lung cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: October 28, 2023

Insight into the significance of CD8+ tumor-infiltrating lymphocytes in squamous cell lung cancer.

Insight into the significance of CD8+ tumor-infiltrating lymphocytes in squamous cell lung cancer.

Journal: Thoracic cancer

Published: October 28, 2023

Showing 1-12 of 55

Last Updated: 09/26/2026